BFM
GOSS icon

Boothbay Fund Management’s Gossamer Bio GOSS Stock Holding History

Boothbay Fund Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.9K Buy
145,800
+8,300
+6% +$13K ﹤0.01% 1929
2025
Q4 		$426K Buy
+137,500
New +$392K 0.01% 1228
2022
Q4 		– Sell
-80,200
Closed -$961K – 2164
2022
Q3 		$961K Buy
80,200
+37,100
+86% +$460K 0.02% 899
2022
Q2 		$361K Buy
+43,100
New +$334K 0.01% 1349
2022
Q1 		– Sell
-20,100
Closed -$227K – 2369
2021
Q4 		$227K Buy
20,100
+1,600
+9% +$19K 0.01% 1423
2021
Q3 		$233K Buy
+18,500
New +$170K 0.01% 1478
2021
Q2 		– Sell
-306
Closed -$283K – 1952
2021
Q1 		$283K Sell
306
-92
-23% -$928 0.01% 1220
2020
Q4 		$385K Buy
+398
New +$3.92K 0.01% 852
2019
Q4 		– Sell
-976
Closed -$1.64M – 892
2019
Q3 		$1.64M Buy
+976
New +$19.4K 0.15% 186

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Boothbay Fund Management's GOSS Position: Q1 2024 in Review

Boothbay Fund Management sold out of Gossamer Bio (GOSS) in Q1 2024, closing a stake of 58,335 shares — an estimated $53.2K sold.

Boothbay Fund Management first reported a position in GOSS in Q1 2019 and held it in 12 quarters. The position peaked at $1.69M in Q3 2021. 110 funds tracked by Wall St. Rank hold GOSS as of Q1 2024.

  • Boothbay Fund Management reported no remaining Gossamer Bio position as of Q1 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 58,335 Gossamer Bio shares in Q1 2024, an estimated $53.2K.
  • Boothbay Fund Management first reported a position in Gossamer Bio in Q1 2019 and held it in 12 quarters.
  • Boothbay Fund Management's Gossamer Bio position peaked at $1.69M in Q3 2021.
  • 110 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2024.

Based on Boothbay Fund Management's 13F filing for Q1 2024, filed 15 May 2024.